Look At Analyst Expectations For A Better Read On Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -0.13% and -12.80% over the past three months. BMY shares are trading 14.68% year to date (YTD), with the 12-month market performance down to -17.15% lower. […]
Bristol-Myers Squibb Co (NYSE: BMY) Has Another Chance To Impress You
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 0.30% and -19.60% over the past three months. BMY shares are trading 14.93% year to date (YTD), with the 12-month market performance down to -17.80% lower. […]
Look At Analyst Expectations For A Better Read On Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.09% and -21.31% over the past three months. BMY shares are trading 9.86% year to date (YTD), with the 12-month market performance down to -18.05% lower. […]
Bristol-Myers Squibb Co (NYSE: BMY): Hunting Genuine Value In Market Debris
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -7.56% and -22.44% over the past three months. BMY shares are trading 14.38% year to date (YTD), with the 12-month market performance down to -17.15% lower. […]
Bristol-Myers Squibb Co (BMY): Street Finally Waking Up
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -0.69% and -18.89% over the past three months. BMY shares are trading -13.97% year to date (YTD), with the 12-month market performance up to 14.74% higher. […]
Look At Analyst Expectations For A Better Read On Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 0.43% and -22.36% over the past three months. BMY shares are trading -13.37% year to date (YTD), with the 12-month market performance up to 18.82% higher. […]
Bristol-Myers Squibb Co (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 2.66% and -19.02% over the past three months. BMY shares are trading -14.64% year to date (YTD), with the 12-month market performance up to 19.24% higher. […]
Analyst Expect Big Moves From Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.04B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.99% and -13.25% over the past three months. BMY shares are trading -16.51% year to date (YTD), with the 12-month market performance up to 5.99% higher. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]